Yüklüyor......
Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation
The concentrations required for curcumin to exert its anticancer activity (IC(50), 20 µM) are difficult to achieve in the blood plasma of patients, due to the low bioavailability of the compound. Therefore, much effort has been devoted to the development of curcumin analogues that exhibit stronger a...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888218/ https://ncbi.nlm.nih.gov/pubmed/27313760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4536 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|